We assessed the seroprevalence of antibodies to Trypanosoma cruzi among pre
gnant Hispanic women in Houston. Sera from 2,107 Hispanic and 1,658 non-His
panic subjects were tested by ELISA for the presence of antibodies to T. cr
uzi. Twenty-two (0.6%) of 3,765 subjects had sera that were reactive. Seror
eactivity was confirmed by hemagglutination assay. Eleven subjects had reac
tive sera, giving a confirmed seroprevalence of 0.3% (95% CI, 0-1%). Nine s
era from Hispanic and two from non-Hispanic women were positive by hemagglu
tination assay, for a prevalence of 0.4% and 0.1%, respectively, during pre
gnancy. On the basis of these seroreactivity data, transplacental transmiss
ion of T. cruzi could occur in the continental United States. Screening for
antibodies to T. cruzi during pregnancy would provide the potential for ea
rly intervention in congenital Chagas' disease.